Abstract
Methyl-5(or 4)-(3,3-dimethyl-1-triazeno)-imidazole-4(or 5)-carboxylate was shown to have in vitro antimicrobial activity against gram-positive and gram-negative bacteria, yeasts, filamentous fungi, and algae. Preliminary studies with mice, experimentally infected with Staphylococcus aureus, have shown that this new antimicrobial agent has in vivo chemotherapeutic activity comparable to that observed with penicillin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hunt D. E., Pittillo R. F. Antifungal action of 1,3-bis(2-chloroethyl)-1-nitrosourea. Antimicrob Agents Chemother (Bethesda) 1965;5:710–716. [PubMed] [Google Scholar]
- SHEALY Y. F., MONTGOMERY J. A., LASTER W. R., Jr Antitumor activity of triazenoimidazoles. Biochem Pharmacol. 1962 Jul;11:674–676. doi: 10.1016/0006-2952(62)90130-2. [DOI] [PubMed] [Google Scholar]
- Shealy J. F., Krauth C. A., Pittillo R. F., Hunt D. E. A new antifungal and antibacterial agent, methyl 5(or 4)-(3,3-dimethyl-1-triazeno)imidazole-4(or 5)-carboxylate. J Pharm Sci. 1967 Jan;56(1):147–148. doi: 10.1002/jps.2600560133. [DOI] [PubMed] [Google Scholar]
- Shealy Y. F., Krauth C. A. Complete inhibition of mouse leukaemia L1210 by 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196). Nature. 1966 Apr 9;210(5032):208–209. doi: 10.1038/210208a0. [DOI] [PubMed] [Google Scholar]